Weekly Round Up

Research Deep DiveLong Form ArticleWeekly Round Up
Weekly Round UpWeekly Round Up
The $8.55T Shift Reshaping Healthcare — And What Comes Next

The $8.55T Shift Reshaping Healthcare — And What Comes Next

Value-based care, private equity, and GenAI are redrawing healthcare’s financial map. The next phase isn’t about growth alone—it’s about redefining where and how value is created.

Weekly Round UpWeekly Round Up
The $37B Boom: Can Gamification Really Heal Healthcare?

The $37B Boom: Can Gamification Really Heal Healthcare?

Gamification is transforming patient engagement and digital care—but can it truly heal what healthcare can’t?

Weekly Round UpWeekly Round Up
Wellness Booms, AI Crawls, and Europe Leaves the U.S. Behind

Wellness Booms, AI Crawls, and Europe Leaves the U.S. Behind

Global wellness spending just passed $5 trillion, fueled by products, tech, and lifestyle real estate. The market’s flexing fast—and only investors who adapt to this convergence will keep up.

Weekly Round UpWeekly Round Up
Healthcare Cybersecurity Is Booming — Don’t Get Left Behind

Healthcare Cybersecurity Is Booming — Don’t Get Left Behind

The healthcare cybersecurity market is set to nearly quadruple to $126B by 2034. Investors, providers, and tech players who move now will define the next decade of digital trust.

Weekly Round UpWeekly Round Up
Pharma’s $3 Trillion Path and Pfizer’s $7.3B Obesity Push

Pharma’s $3 Trillion Path and Pfizer’s $7.3B Obesity Push

Global pharma races toward $3 trillion as Asia accelerates growth, while Pfizer doubles down on obesity drugs with a $7.3B bet.

Weekly Round UpWeekly Round Up
Distrust in Vaccines: The Hidden Risk for Biopharma Growth

Distrust in Vaccines: The Hidden Risk for Biopharma Growth

Vaccine distrust is reshaping biopharma valuations, slowing adoption, and adding hidden risks for investors.

Weekly Round UpWeekly Round Up
From Line Item to National Imperative: The $36B Trauma Bet

From Line Item to National Imperative: The $36B Trauma Bet

Trauma care is no longer just an emergency response—it’s a growth sector projected to nearly double by 2034.

Weekly Round UpWeekly Round Up
GenAI Hits Healthcare: Innovation or Regulation Roadblock?

GenAI Hits Healthcare: Innovation or Regulation Roadblock?

Generative AI is no longer just hype—it’s entering clinics, hospitals, and care networks with unprecedented speed.

Weekly Round UpWeekly Round Up
Blockchain’s $193B Bet on Healthcare | Hear From Jon Ledecky, Bobby Sharma, Julia Wittlin, Ben Fund & More

Blockchain’s $193B Bet on Healthcare | Hear From Jon Ledecky, Bobby Sharma, Julia Wittlin, Ben Fund & More

The blockchain healthcare market is set to explode from $9.6B in 2024 to $193B by 2034.

Weekly Round UpWeekly Round Up
2025: Healthcare’s Great Separation: What Every Executive Needs to Know

2025: Healthcare’s Great Separation: What Every Executive Needs to Know

Signal over noise: H2 favors platform scale, disciplined buyers, and the $4.91T biotech tailwind.

Weekly Round UpWeekly Round Up
Supply Problem, PE Solution: The Rural Health Platform Play

Supply Problem, PE Solution: The Rural Health Platform Play

Convert supply constraints into scale—MA roll-ups, tele-specialty networks, and mobile clinics where policy tailwinds meet unmet demand.

Weekly Round UpWeekly Round Up
KKR’s Bold Biopharma Play | Europe’s Hidden Healthcare Risk | AI’s Global Imbalance

KKR’s Bold Biopharma Play | Europe’s Hidden Healthcare Risk | AI’s Global Imbalance

Biopharmaceutical industry is expected to hit $1.8 trillion by 2034, North America still dominates half of the world in AI applications to healthcare.